| 摘要 |
PCT No. PCT/GB94/02145 Sec. 371 Date Oct. 28, 1996 Sec. 102(e) Date Oct. 28, 1996 PCT Filed Oct. 4, 1994 PCT Pub. No. WO95/09841 PCT Pub. Date Apr. 13, 1995A compound of formula (I): <IMAGE> (I) wherein: R1 represents a (C1-C6)alkyl, phenyl, substituted phenyl, or heterocyclyl group; R2 represents a (C1-C6)alkyl group; R3 represents: (I) the side chain of arginine, lysine, tryptophan, histidine, serine, threonine, or cysteine, in which any polar amino, hydroxy, mercapto, guanidyl, imidazolyl or indolyl group is rendered substantially non-polar by substitution at the polar N-, O- or S-atom; or (ii) the side chain of aspartic or glutamic acid, in which side chain the carboxylic acid group is amidated; R4 represents hydrogen or a (C1-C6)alkyl or phenyl (C1-C6)alkyl group; R5 represents hydrogen or and n is 0, 1 or 2; or substituted phenyl groups; or a salt solvate or hydrate thereof. Compositions containing compound (I) and methods for treatment of diseases or conditions mediated by TNF or MMPs in mammals. |
